3-Chloro-5-(trifluoromethyl)pyridine | CAS:85148-26-1

We serve 3-Chloro-5-(trifluoromethyl)pyridine CAS:85148-26-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
3-Chloro-5-(trifluoromethyl)pyridine

Chemical Name:3-Chloro-5-(trifluoromethyl)pyridine
CAS.NO:85148-26-1
Synonyms:3-Chloro-5-(trifluoromethyl)pyridine
3-Chloro-5-trifluoromethylpyridine
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 146.0±35.0 °C at 760 mmHg
Molecular Formula C6H3ClF3N
Molecular Weight 181.543
Flash Point 42.1±25.9 °C
Vapour Pressure 6.0±0.3 mmHg at 25°C
Index of Refraction 1.447
 
Specification:
Appearance:Off-white crystalline powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 3-Chloro-5-(trifluoromethyl)pyridine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Chloro-5-trifluoromethylpyridine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Chloro-5-(trifluoromethyl)pyridine Use and application,3-Chloro-5-(trifluoromethyl)pyridine technical grade,usp/ep/jp grade.


Related News: From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats.1-(biphenyl-4-yl)-2-methyl-2-morpholinopropan-1-one manufacturer Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.((5-Thiazolyl)methyl)-(4-nitrophenyl)carbonate supplier Madeleine Roche, Associate Pharmaceutical Analyst at GlobalData, comments: “Within the top 20 global companies that spent the most on R&D in 2018, the top spender – despite having the second smallest annual revenue of the group at $15.28 billion – is Celgene, whose R&D spend was equal to 37% of its annual revenue.N-Boc-L-Prolinol vendor Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs.It does not require a production license for the drug substance, and can be produced in an ordinary chemical plant. As long as it reaches a certain level, it can be used for the synthesis of the drug substance.